CannaPharmaRX (CPMD) Stock Chart & Stock Price History → Elon Musk’s Controversial New Project: “Apollo” (From InvestorPlace) (Ad) Free CPMD Stock Alerts $0.01 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share ChartStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest CannaPharmaRX Stock Price Performance5 Day PerformanceN/A1 Month Performance-44.44%3 Month Performance+900.00%6 Month Performance+25.00%Year-To-Date Performance+488.24%1 Year Performance-2.91% Receive CPMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressBitcoin Rockets To Record High But Buy THIS InsteadRecently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. CPMD Stock Chart for Wednesday, April, 24, 2024 CPMD Chart by TradingView CannaPharmaRX Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/18/2024$0.01$0.01$0.01$0.0150,000 shs$6.61 million04/17/2024$0.01$0.01-22.48%$0.01$0.0150,000 shs$6.61 million04/16/2024$0.02$0.01-14.00%$0.02$0.01405,200 shs$8.52 million04/15/2024$0.01$0.02+7.14%$0.02$0.01704,723 shs$9.91 million04/12/2024$0.02$0.01-9.68%$0.01$0.011.17 million shs$9.25 million04/11/2024$0.01$0.02+9.93%$0.02$0.011.39 million shs$8.65 million Get the Latest News and Ratings for CPMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. 04/10/2024$0.01$0.01$0.02$0.0182,872 shs$7.87 million04/09/2024$0.02$0.01-17.06%$0.02$0.0182,672 shs$7.87 million04/08/2024$0.01$0.02+21.43%$0.02$0.01886,069 shs$9.48 million04/05/2024$0.02$0.02+6.25%$0.02$0.01886,069 shs$9.48 million04/04/2024$0.02$0.02$0.02$0.011.08 million shs$8.92 million04/03/2024$0.02$0.02-6.98%$0.02$0.011.03 million shs$8.92 million04/02/2024$0.02$0.02-7.03%$0.02$0.021.49 million shs$9.59 million04/01/2024$0.01$0.02+25.00%$0.02$0.011.06 million shs$10.32 million03/29/2024$0.01$0.01$0.02$0.012.14 million shs$8.26 million03/28/2024$0.02$0.01-16.38%$0.02$0.012.14 million shs$8.26 million03/27/2024$0.02$0.02+7.27%$0.02$0.01752,511 shs$9.87 million03/26/2024$0.02$0.02-12.70%$0.02$0.011.22 million shs$9.20 million03/25/2024$0.02$0.02+5.00%$0.02$0.012.58 million shs$10.54 million03/22/2024$0.02$0.02+5.88%$0.03$0.021.16 million shs$10.04 million03/21/2024$0.01$0.02+20.57%$0.02$0.01962,801 shs$9.48 million03/20/2024$0.02$0.01-7.24%$0.02$0.01388,137 shs$7.87 million03/19/2024$0.01$0.02+26.67%$0.02$0.012.82 million shs$8.48 million03/18/2024$0.01$0.01-4.00%$0.02$0.014.18 million shs$6.97 million03/15/2024$0.01$0.01-6.72%$0.02$0.014.33 million shs$6.97 million03/14/2024$0.02$0.01-13.55%$0.02$0.012.69 million shs$7.24 million03/13/2024$0.02$0.02+3.33%$0.02$0.013.01 million shs$8.38 million03/12/2024$0.02$0.02-5.06%$0.02$0.022.09 million shs$8.11 million03/11/2024$0.02$0.02-18.97%$0.02$0.021.41 million shs$8.54 million03/08/2024$0.02$0.02-2.50%$0.02$0.021.36 million shs$10.54 million03/07/2024$0.02$0.02+11.11%$0.02$0.025.89 million shs$10.81 million03/06/2024$0.02$0.02+20.00%$0.02$0.014.47 million shs$9.73 million03/05/2024$0.01$0.02+15.38%$0.02$0.013.89 million shs$8.11 million03/04/2024$0.01$0.01+30.00%$0.01$0.013.47 million shs$7.03 million03/01/2024$0.01$0.01-9.09%$0.01$0.011.09 million shs$5.40 million02/29/2024$0.01$0.01$0.01$0.011.57 million shs$5.94 million02/28/2024$0.01$0.01+10.00%$0.01$0.011.47 million shs$5.94 million02/27/2024$0.01$0.01$0.01$0.011.37 million shs$5.40 million02/26/2024$0.01$0.01+12.36%$0.01$0.01700,677 shs$5.40 million02/23/2024$0.01$0.01-1.11%$0.01$0.011.35 million shs$4.81 millionElon Musk’s Controversial New Project: “Apollo” (Ad)Have you seen this footage outside the headquarters of Elon Musk's "Project Apollo?" Big Tech and the mainstream media have called this project "controversial"...Click here to see the details because there's a lot of money at stake.02/22/2024$0.01$0.01+15.38%$0.01$0.011.41 million shs$4.86 million02/21/2024$0.01$0.01+20.00%$0.01$0.006.28 million shs$4.22 million02/20/2024$0.00$0.01+62.50%$0.01$0.002.55 million shs$3.51 million02/19/2024$0.00$0.00$0.00$0.003.72 million shs$2.16 million02/16/2024$0.00$0.00+60.00%$0.00$0.003.72 million shs$2.16 million02/15/2024$0.00$0.00+25.00%$0.00$0.002.53 million shs$1.23 million02/14/2024$0.00$0.00+17.65%$0.00$0.001.86 million shs$987,000.0002/13/2024$0.00$0.00-5.56%$0.00$0.0015,000 shs$839,000.0002/12/2024$0.00$0.00+157.14%$0.00$0.00967,200 shs$889,000.0002/09/2024$0.00$0.00-22.22%$0.00$0.003.47 million shs$346,000.0002/08/2024$0.00$0.00-10.00%$0.00$0.002.97 million shs$444,000.0002/07/2024$0.00$0.00$0.00$0.001.09 million shs$494,000.0002/06/2024$0.00$0.00$0.00$0.002.94 million shs$494,000.0002/05/2024$0.00$0.00$0.00$0.00628,343 shs$494,000.0002/02/2024$0.00$0.00$0.00$0.0055,120 shs$494,000.0002/01/2024$0.00$0.00-9.09%$0.00$0.002.18 million shs$494,000.0001/31/2024$0.00$0.00+10.00%$0.00$0.004.52 million shs$525,000.0001/30/2024$0.00$0.00-28.57%$0.00$0.001.79 million shs$477,000.0001/29/2024$0.00$0.00$0.00$0.008.21 million shs$668,000.0001/26/2024$0.00$0.00+16.67%$0.00$0.0066,425 shs$668,000.0001/25/2024$0.00$0.00+20.00%$0.00$0.006,211 shs$572,000.0001/24/2024$0.00$0.00-16.67%$0.00$0.007.20 million shs$461,000.0001/23/2024$0.00$0.00-29.41%$0.00$0.00864,000 shs$553,000.00 Related Companies: Alterity Therapeutics Stock Chart Aeterna Zentaris Stock Chart Moleculin Biotech Stock Chart Galera Therapeutics Stock Chart Biofrontera Stock Chart Akari Therapeutics Stock Chart Guardion Health Sciences Stock Chart Adial Pharmaceuticals Stock Chart Elevai Labs Stock Chart Purple Biotech Stock Chart Receive CPMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CannaPharmaRX and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:CPMD) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CannaPharmaRX, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.